Apolipoprotein E genotypes do not influence the age of onset in Huntington's disease. - Wikidata - awgldk - TriplyDB

Apolipoprotein E genotypes do not influence the age of onset in Huntington's disease.

Apolipoprotein E genotypes do not influence the age of onset in Huntington's disease.

http://www.wikidata.org/entity/Q35478096

about

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy The role of apolipoprotein E as a risk factor for an earlier age at onset for Machado-Joseph disease is doubtful.HDL and cognition in neurodegenerative disorders.Function and comorbidities of apolipoprotein e in Alzheimer's disease.A single nucleotide polymorphism in the coding region of PGC-1α is a male-specific modifier of Huntington disease age-at-onset in a large European cohort.Apolipoprotein E alleles can contribute to the pathogenesis of numerous clinical conditions including HSV-1 corneal disease.Re-assessing the relationship between cholesterol, statins and Alzheimer's disease.Interventions for heart disease and their effects on Alzheimer's disease.Replication of twelve association studies for Huntington's disease residual age of onset in large Venezuelan kindreds.Huntington's Disease: Relationship Between Phenotype and Genotype.Psychiatric and cognitive symptoms in Huntington's disease are modified by polymorphisms in catecholamine regulating enzyme genes.Huntington's disease: the case for genetic modifiers.Molecular characterization of genes modifying the age at onset in Huntington's Disease in Uruguayan patients.APOE alleles in Parkinson disease and their relationship to cognitive decline: a population-based, longitudinal study.

P2860

Q28282855-A07D1F07-FFEB-431B-AE04-3FBC21712965 Q34450271-11ECF2A8-4DB9-44FA-9153-4DB9A7ACC80D Q34614842-662DDC38-A8B8-4C8C-9209-B816D0EDF9F6 Q34951817-9F9A6C30-9DDC-488E-9922-AEA7091F5907 Q35079574-A0F8D85E-1202-46EC-B9AF-C31AAD3C8A72 Q36412999-7BEFD2C9-D676-4B42-AF9C-4548E8090D4E Q36546507-232A8133-1CE0-44B9-A0FE-1464EF7706F0 Q36582781-A251841A-36F7-4C7A-A638-4E56FD770EFA Q37004508-013AC955-167B-4FE5-8C16-053702877E55 Q38689609-2971983F-B087-466E-9EEF-3CDC06171191 Q38994978-D4675929-7294-4AB4-A544-9B9507E7AD4F Q42181050-3962E99A-39D2-47D8-AF99-F3322BB598CC Q45306073-B6C45585-A076-42DD-82DA-728154316E75 Q51750801-AABBD76F-8B09-46EF-BE66-A33C1FAD51B9

P2860

Apolipoprotein E genotypes do not influence the age of onset in Huntington's disease.

http://www.wikidata.org/entity/Q35478096

description

2004 nî lūn-bûn

@nan

2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

name

Apolipoprotein E genotypes do not influence the age of onset in Huntington's disease.

@ast

Apolipoprotein E genotypes do not influence the age of onset in Huntington's disease.

@en

type

label

Apolipoprotein E genotypes do not influence the age of onset in Huntington's disease.

@ast

Apolipoprotein E genotypes do not influence the age of onset in Huntington's disease.

@en

prefLabel

Apolipoprotein E genotypes do not influence the age of onset in Huntington's disease.

@ast

Apolipoprotein E genotypes do not influence the age of onset in Huntington's disease.

@en

P1433

Q35478096-E9658AFC-55C0-4E7D-847B-FFD82F1ED59A

P1476

Q35478096-EA1F891C-7505-48BA-B8D5-74F23227D366

P2093

Q35478096-08ED2356-3A40-4470-8704-22E28755E991

Q35478096-54ADBA55-E33E-4AD9-A118-9B230F8EB6C6

Q35478096-666193EB-15DC-4E97-B9EA-C0B74A6BB963

Q35478096-7161E116-CCCC-4DAB-A0C5-AA12884B5FA9

Q35478096-C64853C6-1170-478D-9060-4F84B1FD4731

P2860

Q35478096-135B2F65-FDB5-46DF-9464-961214408460

Q35478096-1D6F95CF-97CC-45B7-A821-53983D3DA75A

Q35478096-29D4D1D4-AAC0-469D-9B5D-B62FD0A6D019

Q35478096-4D96B044-A3AD-4E95-B5E6-BCC9014E6852

Q35478096-4E26CBE5-3FCB-43CA-8657-F0CEDDDC0972

Q35478096-515028DC-A3A3-4CB3-AEEC-75B3EEC6791D

Q35478096-605F48C9-EA4E-4603-92AF-08B40FD58EDD

Q35478096-6627CF1A-294C-4112-B2E7-806F3921237B

Q35478096-7223E361-0756-436F-A75F-B46738B92EA9

Q35478096-74E6C3AB-6603-47C2-98C2-4EFD932D60B0

P304

Q35478096-380E6DE1-7C72-4F92-9C73-7F26C1B1BD06

P31

Q35478096-6632E9B2-3D48-406B-A8F5-A2F61C20BC2C

P356

Q35478096-57021369-7C6F-44C3-813E-B92D17FD152F

P407

Q35478096-5A7CF40F-C724-4865-AC3B-342E64FB0BC1

P433

Q35478096-55DA55B7-264E-4944-8B38-5CB70899950D

P478

Q35478096-F9344294-31D2-4F88-B862-22CC4B56060D

P50

Q35478096-04BBBAB0-E5F1-47AB-9D1D-C37534E6C1EA

Q35478096-22C0133A-E4DF-4EF1-85B5-ACE683F9C8F0

P577

Q35478096-71B22DD1-8BB3-426B-AD2B-A53B41CF1D84

P5875

Q35478096-B6533F8E-FB46-4324-AD7F-34FF4F7D82BE

P698

Q35478096-F3677C6E-2E9E-4143-B9DA-4AAB8928DB24

P921

Q35478096-73C32EDB-C311-44C5-AFD4-554EAD5404A7

P932

Q35478096-3AFC58DC-6E54-4A32-98A3-DE317ED0927C

P356

JNNP.2003.022756

P1433

Journal of Neurology, Neurosurgery and Psychiatry

P1476

Apolipoprotein E genotypes do not influence the age of onset in Huntington's disease

@en

P2093

H Przuntek

http://www.w3.org/2001/XMLSchema#string

J E Andrich

http://www.w3.org/2001/XMLSchema#string

M Gencik

http://www.w3.org/2001/XMLSchema#string

N Brune

http://www.w3.org/2001/XMLSchema#string

P H Kraus

http://www.w3.org/2001/XMLSchema#string

P2860

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

Apolipoprotein E: far more than a lipid transport protein

The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease

Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond.

Recent advances in Huntington's disease: implications for experimental therapeutics.

Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length.

Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats.

Cause of neural death in neurodegenerative diseases attributable to expansion of glutamine repeats.

P304

1692-1696

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JNNP.2003.022756

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

75

http://www.w3.org/2001/XMLSchema#string

P50

Joerg T. Epplen

P577

2004-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8179614

http://www.w3.org/2001/XMLSchema#string

P698

15548484

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease

P932

1738834

http://www.w3.org/2001/XMLSchema#string